Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 14 Patents
Compositions and methods for treating cancer with anti-CD123 immunotherapy

16-07-2024 • US-12037403-B2

ORENTAS, RIMAS J. • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

30-04-2024 • US-11970528-B2

ORENTAS, RIMAS • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-CD22 immunotherapy

23-01-2024 • US-11878052-B2

ORENTAS, RIMAS J. • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-CD19 immunotherapy

25-07-2023 • US-11708408-B2

SCHNEIDER, DINA • ORENTAS, RIMAS J. • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-CD33 immunotherapy

11-10-2022 • US-11464801-B2

ORENTAS, RIMAS • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

27-09-2022 • US-11453719-B2

ORENTAS, RIMAS J. • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-CD38 immunotherapy

31-08-2021 • US-11103533-B2

SCHNEIDER, DINA • ORENTAS, RIMAS J. • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-CD123 immunotherapy

24-11-2020 • US-10844128-B2

ORENTAS, RIMAS J. • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

04-02-2020 • US-10550179-B2

ORENTAS, RIMAS J. • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-CD22 immunotherapy

28-01-2020 • US-10543263-B2

ORENTAS, RIMAS J. • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-CD19 immunotherapy

10-12-2019 • US-10501539-B2

SCHNEIDER, DINA • ORENTAS, RIMAS J. • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

01-10-2019 • US-10428141-B2

ORENTAS, RIMAS J. • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-CD33 immunotherapy

01-10-2019 • US-10426797-B2

ORENTAS, RIMAS • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

22-01-2019 • US-10183993-B2

ORENTAS, RIMAS • SCHNEIDER, DINA • DROPULIC , BORO • DIMITROV, DIMITER S. • ZHU, ZHONGYU

Lentigen Technology Inc • US Department of Health and Human Services

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.